Shopping Cart
- Remove All
- Your shopping cart is currently empty
CC214-1 is an mTOR inhibitor with potential anticancer activity, inhibits protein translation, and induces autophagy. CC214-1 is an in vitro tool compound for exploring the biology of mTOR kinases and can be used to study myeloma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $483 | In Stock | |
10 mg | $692 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,490 | In Stock | |
100 mg | $1,970 | In Stock |
Description | CC214-1 is an mTOR inhibitor with potential anticancer activity, inhibits protein translation, and induces autophagy. CC214-1 is an in vitro tool compound for exploring the biology of mTOR kinases and can be used to study myeloma. |
Targets&IC50 | mTOR:0.002 μM |
In vitro | CC214-1 (0,0.1,1,2,5,10 μM, 8h; 2μM, 24h)Inhibited mTORC1 signaling in all glioblastoma cell lines tested, potently suppressing rapamycin-resistant 4E-BP1 and mTORC2 signaling[1]. |
Molecular Weight | 391.43 |
Formula | C20H21N7O2 |
Cas No. | 1021920-32-0 |
Smiles | O=C1NC2=NC=C(N=C2N1CCC3CCOCC3)C=4C=CC(=CC4)C5=NN=CN5 |
Relative Density. | 1.326 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.